FAQ

Cell line selection involves isolating primary cells from an animal tissue sample and characterizing them using advanced bioanalytical methods to find the optimal candidates for upscaling. Scientists look for specific performance metrics, primarily rapid cell growth rates, high doubling capacity, and long-term phenotypic stability across multiple passages. The cell lines that demonstrate the most robust bioprocess characteristics are then selected to become the foundational banks for large-scale production.

Cultivated meat (also known as cultured or cell-based meat) is genuine animal meat produced by growing animal cells directly within a controlled bioreactor environment. The process begins with a harmless tissue biopsy from an animal (such as a chicken, cow, or pig). These cells are fed a nutrient-rich media, allowing them to proliferate and differentiate into muscle, fat, and connective tissues. This cellular agriculture methodology bypasses traditional livestock rearing, drastically reducing environmental impact and animal suffering.

Epigenetics bridges a critical data gap in cellular agriculture by providing a stable, definitive map of true cell identity and differentiation potential. Traditional cell line characterization relies heavily on temporary biomarkers like RNA or proteins. However, epigenetic profiling (specifically tracking DNA methylation) reveals whether a cell line will reliably remain a muscle or fat cell during upscaling, or if it risks losing its identity during the high-stress bioreactor expansion phase.

Epigenetic profiling is superior because it measures stable, long-term cell identity, whereas transcriptomics (RNA) and proteomics (proteins) only capture a transient snapshot of cell behavior at a single moment in time. RNA and protein expressions fluctuate wildly based on minor, temporary changes in bioreactor temperature, pH, or media composition. In contrast, epigenetic signatures remain highly stable across high passage numbers, making them the only reliable metric for predicting long-term cell line stability and downstream performance.

EpiTrace reduces biomanufacturing costs by enabling high-potential cell line selection at the earliest stages of development, preventing expensive timeline delays. Traditional methods require weeks or months of running pilot-scale growth experiments only to discover a cell line performs poorly at high passages. By utilizing EpiTrace’s epigenetic data, companies can fast-track high-yielding, stable cell lines early, drastically optimizing R&D spend and shortening the time-to-market.

Yes. EpiTrace possesses robust proof-of-concept data demonstrating our platform's ability to successfully analyze cultured meat cell lines. Our assays can distinguish between different tissue types (e.g., muscle vs. fat) and also distinguish between cells from a conventional meat product vs a cultured meat product with high accuracy, validating our technology as a commercial-grade quality control tool.

The primary regulatory hurdle for novel food approval is proving the exact nature, consistency, and genomic stability of the cell product across the entire production lifecycle. Regulatory bodies, such as the FDA, EFSA, and Singapore's SFA, require deep documentation showing that the cells harvested at the end of a commercial run are safe, unmutated, and identical in composition to the original cell bank. Traditional analytical methods struggle to provide this level of deep longitudinal consistency data.

EpiTrace provides the rigorous, quantitative data required by regulators to verify product safety, purity, and genomic stability. By analyzing the unique DNA methylation signatures of the final cultivated meat product, EpiTrace delivers a highly reproducible audit trail. This data proves to regulatory inspectors that the cell lines have not undergone hazardous genetic drift or unintended mutations during massive bioreactor expansion, significantly streamlining the dossier submission process.

Food fraud in this sector presents a two-way economic risk as production scales globally:

1. Premium Fraud (Current Risk): Because cultivated meat is currently expensive and commands a premium price point, bad actors may attempt to pass off cheap, conventionally slaughtered meat as high-value cultured meat.
2. Substitution Fraud (Future Risk): As biomanufacturing scales and cultivation costs drop below the price of conventional livestock farming, there will be an economic incentive to fraudulently sell cultured meat as traditional conventional meat.

To maintain market trust and protect brand integrity, the industry requires an uncheatable analytical method to verify exact product origins.

Cultivated meat and conventional meat can be accurately distinguished by analyzing their unique epigenetic signatures. As food tech advances, the taste, texture, and nutritional profiles of cultured meat will perfectly mimic conventional tissue, making chemical or sensory testing obsolete. However, because cells grown in a bioreactor experience completely different environments than animals raised on a farm, their DNA methylation patterns are vastly different. EpiTrace detects these distinct epigenetic fingerprints, providing a foolproof verification tool for supply chain integrity.